Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

QGEN - Qiagen NV


Close
45.71
0.030   0.066%

Share volume: 1,668,925
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$45.68
0.03
0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
24%
Profitability 21%
Dept financing 37%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
-1.21%
1 Month
2.24%
3 Months
7.20%
6 Months
5.81%
1 Year
-0.86%
2 Year
0.78%
Key data
Stock price
$45.71
P/E Ratio 
143.49
DAY RANGE
$45.49 - $46.24
EPS 
$0.32
52 WEEK RANGE
$34.77 - $47.44
52 WEEK CHANGE
$0.02
MARKET CAP 
10.431 B
YIELD 
N/A
SHARES OUTSTANDING 
228.203 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/28/2024
BETA 
0.75
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,535,610
AVERAGE 30 VOLUME 
$1,098,739
Company detail
CEO: Thierry Bernard
Region: US
Website: https://www.qiagen.com/
Employees: 5,070
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from blood, tissue and other materials. assay technologies make these biomolecules visible and ready for analysis. bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. automation solutions tie these together in seamless and cost-effective molecular testing workflows. qiagen provides these workflows to more than 500,000 customers around the world in molecular diagnostics (human healthcare), applied testing (forensics, veterinary testing and food safety), pharma (pharmaceutical and biotechnology companies) and academia (life sciences research). as of june 30, 2015, qiagen employed approximately 4,400 people in over 35 locations worldwide. further information can be found at http://www.qiagen.com.

Recent news